A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom
Crossref DOI link: https://doi.org/10.1007/s12325-017-0483-1
Published Online: 2017-01-31
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Johnston, Robert L.
Carius, Hans-Joachim
Skelly, Adrian
Ferreira, Alberto
Milnes, Fran
Mitchell, Paul
Funding for this research was provided by:
Novartis
Text and Data Mining valid from 2017-01-31
Article History
Received: 24 November 2016
First Online: 31 January 2017